TrialInternational urology and nephrology2025

Teverelix is a potential treatment option for the prevention of acute urinary retention recurrence in men suffering from benign prostatic hyperplasia.

Albertas Ulys et al.PubMed ↗Publisher ↗

No numbers read from the abstract.